Search results
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Fina
Guru Focus· 14 hours agoRevenue: Reported at $1.5 million for Q1 2024, a significant decrease from $6.7 million in Q1 2023, falling short of the estimated $2.15 million.Net Loss: Reco